Cargando…
Pharmacological, Biochemical and Immunological Studies on Protective Effect of Mangiferin in 6-Hydroxydopamine (6-OHDA)-Induced Parkinson’s Disease in Rats
BACKGROUND: Parkinson’s disease is a neurodegenerative disorder and is marked by inflammation and death of neurons in the striatum region of the midbrain. It has been reported that expression of NF-κB increases during Parkinson’s disease, which promotes oxidative stress, stimulates release of proinf...
Autores principales: | Tiwari, Prafulla Chandra, Chaudhary, Manju J., Pal, Rishi, Kartik, Shipra, Nath, Rajendra |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8948331/ https://www.ncbi.nlm.nih.gov/pubmed/35341236 http://dx.doi.org/10.1177/09727531211051976 |
Ejemplares similares
-
β-Cells Different Vulnerability to the Parkinsonian Neurotoxins Rotenone, 1-Methyl-4-phenylpyridinium (MPP(+)) and 6-Hydroxydopamine (6-OHDA)
por: Carli, Marco, et al.
Publicado: (2021) -
The Release of Norepinephrine in C57BL/6J Mice Treated with 6-Hydroxydopamine (6-OHDA) is Associated with Translocations in Enteric Escherichia coli via the QseC Histidine Kinase Receptor
por: Meng, Jun, et al.
Publicado: (2020) -
Metabolomics and biochemical alterations caused by pleiotrophin in the 6-hydroxydopamine mouse model of Parkinson’s disease
por: Gramage, Esther, et al.
Publicado: (2022) -
EGCG Protects against 6-OHDA-Induced Neurotoxicity in a Cell Culture Model
por: Chen, Dan, et al.
Publicado: (2015) -
Neuroprotective Effect of Quercetin Nanocrystal in a 6-Hydroxydopamine Model of Parkinson Disease: Biochemical and Behavioral Evidence
por: Ghaffari, Fatemeh, et al.
Publicado: (2018)